The latest market report published by Credence Research, Inc. “Bioresorbable Vascular Scaffold Market By Material Type (Polymer Based Stents, Metallic Stents), By Disease Indication (Coronary Heart Disease, Peripheral Artery Disease, Other Cardiovascular Diseases), By End-user (Hospitals, Specialty Clinics, Ambulatory Surgical Centers) - Growth, Future Prospects, and Competitive Analysis, 2019 - 2027”the bioresorbable vascular scaffold market was valued at US$ 165.8 Mn in 2018, expected to grow at a CAGR of 10.3 percent during the forecast period from 2019 to 2027.
Browse the full report at https://www.credenceresearch.com/report/bioresorbable-vascular-scaffold-market
Market Insights
The global market for bioresorbable vascular scaffolding is increasing significantly from 2019 to 2027 and has been accredited to increase hospital admissions for heart-related disorders along with enhanced biosynthetic and polymer technology in the stent industry worldwide. Increased FDA approvals for new coronary stents with upgraded technology, along with large pipeline products in the polymer segment, such as polyesters, corrodible metals, polycarbonates, and bacterial-derived polymers, will drive market growth in the near future. For e.g. in July 2016 Abbott Laboratories received the U.S. FDA approval for Bioresorbable Vascular Scaffold (BVS; Abbott Vascular) for long-term clinical outcomes, primarily designed to overcome metallic stent limitations.
Top corporations are mainly focusing on new product development and FDA clearance on a global scale, mainly in the U.S. and Europe. Increasing number of partnerships and mergers with medical technology organizations and research institutes internationally will boost the market growth internationally. The prominent position of the North America market is primarily accredited to rising prevalence of cardiac and pulmonary disorders, high life expectancy contributing to large pool of geriatric and obese population, better reimbursements to implantable devices and domicile of major market players in the U.S. market. The key factors responsible for driving the market are developing healthcare infrastructure & product accessibility, rising prevalence of cardiac arrhythmia, growing awareness related to early diagnosis & treatment, and new technology expansion along with implantation procedures.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/59857
Key Market Movements:
- Globally, the bioresorbable vascular scaffold is growing at a CAGR of 10.3% for the period from 2019 to 2027
- Factors that contribute to market growth are rising prevalence of cardiac arrhythmia, carotid artery disease, renal artery stenosis, peripheral arterial disease, and other heart related disorders along with increasing surgical procedures globally.
- Rising public health awareness and affordable reimbursement scenario drive the market growth the Asia Pacific region
- Increasing funding by private organizations for expansion of cardiac care hospitals and cardiology centres for better treatment options along with enhanced technology expansion in emerging countries will expand globally
- Major players in this vertical are Cook Medical, Medtronic, plc., Abbott Laboratories, Stentys SA, C. R. Bard, Inc., MAQUET Holding B.V. & Co. KG, Boston Scientific Corporation, Terumo Corporation, W.L. Gore & Associates, Boston Scientific Corporation, AngioDynamics, Inc., Vygon Ltd. and others
- Polymer Based Stents
- Metallic Stents
- Coronary Heart Disease
- Peripheral Artery Disease
- Other Cardiovascular Diseases
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers
- North America
- Europe
- Asia Pacific (APAC)
- Middle East & Africa (MEA)
- Latin America
About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Media Contact
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290
E-mail: sales@credenceresearch.com
Website: http://www.credenceresearch.com
No comments:
Post a Comment